Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
102146435 | 10214643 | 5 | F | 20101026 | 20160802 | 20140603 | 20160810 | EXP | JP-JNJFOC-20140519903 | JANSSEN | 53.28 | YR | A | M | Y | 0.00000 | 20160810 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
102146435 | 10214643 | 1 | PS | INTELENCE | ETRAVIRINE | 1 | Oral | N | 22187 | 200 | MG | TABLETS | BID | ||||||
102146435 | 10214643 | 2 | SS | NORVIR | RITONAVIR | 1 | Oral | 0 | 200 | MG | CAPSULES | QD | |||||||
102146435 | 10214643 | 3 | SS | NORVIR | RITONAVIR | 1 | Oral | 0 | 600 | MG | CAPSULES | QD | |||||||
102146435 | 10214643 | 4 | SS | NORVIR | RITONAVIR | 1 | Oral | 0 | 200 | MG | CAPSULES | QD | |||||||
102146435 | 10214643 | 5 | SS | NORVIR | RITONAVIR | 1 | Oral | 0 | 1200 | MG | CAPSULES | QD | |||||||
102146435 | 10214643 | 6 | SS | NORVIR | RITONAVIR | 1 | Oral | 0 | 600 | MG | CAPSULES | QD | |||||||
102146435 | 10214643 | 7 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 0 | 1 | DF | UNSPECIFIED | QD | |||||||
102146435 | 10214643 | 8 | SS | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | 0 | 800 | MG | TABLET | QD | |||||||
102146435 | 10214643 | 9 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | 0 | 600 | MG | TABLET | BID | |||||||
102146435 | 10214643 | 10 | SS | VIDEX | DIDANOSINE | 1 | Oral | 0 | 200 | MG | UNSPECIFIED | QD | |||||||
102146435 | 10214643 | 11 | SS | VIDEX | DIDANOSINE | 1 | Oral | 0 | 400 | MG | UNSPECIFIED | QD | |||||||
102146435 | 10214643 | 12 | SS | VIDEX | DIDANOSINE | 1 | Oral | 0 | 300 | MG | UNSPECIFIED | QD | |||||||
102146435 | 10214643 | 13 | SS | VIDEX | DIDANOSINE | 1 | Oral | 0 | 50 | MG | UNSPECIFIED | QD | |||||||
102146435 | 10214643 | 14 | SS | VIDEX | DIDANOSINE | 1 | Oral | 0 | 200 | MG | UNSPECIFIED | QD | |||||||
102146435 | 10214643 | 15 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Oral | 0 | 8 | DF | UNSPECIFIED | QD | |||||||
102146435 | 10214643 | 16 | C | CROSS EIGHT M | ANTIHEMOPHILIC FACTOR HUMAN | 1 | 0 | INJECTION | |||||||||||
102146435 | 10214643 | 17 | C | CROSS EIGHT M | ANTIHEMOPHILIC FACTOR HUMAN | 1 | 0 | 1000 | IU | INJECTION | |||||||||
102146435 | 10214643 | 18 | C | URSO | URSODIOL | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
102146435 | 10214643 | 19 | C | URSO | URSODIOL | 1 | Oral | 0 | 300 | MG | UNSPECIFIED | TID | |||||||
102146435 | 10214643 | 20 | C | URSO | URSODIOL | 1 | Oral | 0 | 300 | MG | UNSPECIFIED | TID | |||||||
102146435 | 10214643 | 21 | C | ADVATE | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 1 | Intravenous (not otherwise specified) | 1000UT | 0 | 1 | DF | INJECTION | TIW | ||||||
102146435 | 10214643 | 22 | C | ADVATE | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 1 | Intravenous (not otherwise specified) | 0 | 2 | DF | INJECTION | TIW | |||||||
102146435 | 10214643 | 23 | C | LIVACT | AMINO ACIDS | 1 | Oral | 4.5 G | 0 | 4.15 | G | POWDER | TID | ||||||
102146435 | 10214643 | 24 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | 0 | 20 | MG | TABLETS | QD | |||||||
102146435 | 10214643 | 25 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | 0 | 10 | MG | TABLETS | QD | |||||||
102146435 | 10214643 | 26 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | 0 | 10 | MG | TABLETS | QD | |||||||
102146435 | 10214643 | 27 | C | MUCODYNE | CARBOCYSTEINE | 1 | Oral | 0 | 500 | MG | TABLET | TID | |||||||
102146435 | 10214643 | 28 | C | MEROPENEM. | MEROPENEM | 1 | Intravenous drip | 0 | 1 | G | INJECTION | TID | |||||||
102146435 | 10214643 | 29 | C | MEROPENEM. | MEROPENEM | 1 | Intravenous drip | 0 | 1 | G | INJECTION | BID | |||||||
102146435 | 10214643 | 30 | C | AMIKACIN SULFATE. | AMIKACIN SULFATE | 1 | Unknown | 0 | 400 | MG | INJECTION | QD | |||||||
102146435 | 10214643 | 31 | C | FAROM | FAROPENEM SODIUM | 1 | Oral | 0 | 200 | MG | TABLET | TID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
102146435 | 10214643 | 1 | HIV infection |
102146435 | 10214643 | 2 | HIV infection |
102146435 | 10214643 | 3 | HIV infection |
102146435 | 10214643 | 4 | HIV infection |
102146435 | 10214643 | 5 | HIV infection |
102146435 | 10214643 | 6 | HIV infection |
102146435 | 10214643 | 7 | HIV infection |
102146435 | 10214643 | 8 | HIV infection |
102146435 | 10214643 | 9 | HIV infection |
102146435 | 10214643 | 10 | HIV infection |
102146435 | 10214643 | 11 | HIV infection |
102146435 | 10214643 | 12 | HIV infection |
102146435 | 10214643 | 13 | HIV infection |
102146435 | 10214643 | 14 | HIV infection |
102146435 | 10214643 | 15 | HIV infection |
102146435 | 10214643 | 16 | Factor VIII deficiency |
102146435 | 10214643 | 17 | Factor VIII deficiency |
102146435 | 10214643 | 18 | Liver disorder |
102146435 | 10214643 | 19 | Liver disorder |
102146435 | 10214643 | 20 | Liver disorder |
102146435 | 10214643 | 21 | Factor VIII deficiency |
102146435 | 10214643 | 22 | Factor VIII deficiency |
102146435 | 10214643 | 23 | Liver disorder |
102146435 | 10214643 | 24 | Gastritis |
102146435 | 10214643 | 25 | Gastritis |
102146435 | 10214643 | 26 | Gastritis |
102146435 | 10214643 | 27 | Bronchitis chronic |
102146435 | 10214643 | 28 | Pyelonephritis |
102146435 | 10214643 | 29 | Pyelonephritis |
102146435 | 10214643 | 30 | Pyelonephritis |
102146435 | 10214643 | 31 | Pyelonephritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
102146435 | 10214643 | OT |
102146435 | 10214643 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
102146435 | 10214643 | Dyslipidaemia | |
102146435 | 10214643 | Hepatic cirrhosis | |
102146435 | 10214643 | Hepatocellular carcinoma | |
102146435 | 10214643 | Hyperbilirubinaemia | |
102146435 | 10214643 | Pyelonephritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
102146435 | 10214643 | 1 | 20081011 | 0 | ||
102146435 | 10214643 | 2 | 20060411 | 20110608 | 0 | |
102146435 | 10214643 | 3 | 19990819 | 0 | ||
102146435 | 10214643 | 4 | 20110608 | 0 | ||
102146435 | 10214643 | 5 | 19961218 | 19970924 | 0 | |
102146435 | 10214643 | 6 | 20000401 | 20001228 | 0 | |
102146435 | 10214643 | 7 | 20060401 | 0 | ||
102146435 | 10214643 | 8 | 20080401 | 0 | ||
102146435 | 10214643 | 9 | 20061111 | 0 | ||
102146435 | 10214643 | 10 | 19951018 | 19951206 | 0 | |
102146435 | 10214643 | 11 | 19951206 | 19960313 | 0 | |
102146435 | 10214643 | 12 | 20001229 | 20060410 | 0 | |
102146435 | 10214643 | 13 | 19960724 | 19970924 | 0 | |
102146435 | 10214643 | 14 | 19960313 | 19970924 | 0 | |
102146435 | 10214643 | 15 | 20001229 | 20060410 | 0 | |
102146435 | 10214643 | 16 | 20080401 | 0 | ||
102146435 | 10214643 | 17 | 20100804 | 0 | ||
102146435 | 10214643 | 18 | 200003 | 0 | ||
102146435 | 10214643 | 19 | 20070401 | 20150224 | 0 | |
102146435 | 10214643 | 20 | 20150826 | 0 | ||
102146435 | 10214643 | 21 | 20100805 | 0 | ||
102146435 | 10214643 | 22 | 20140401 | 0 | ||
102146435 | 10214643 | 23 | 20090803 | 0 | ||
102146435 | 10214643 | 24 | 20120401 | 20130821 | 0 | |
102146435 | 10214643 | 25 | 20080924 | 20120331 | 0 | |
102146435 | 10214643 | 26 | 20140319 | 0 | ||
102146435 | 10214643 | 27 | 20090617 | 20150224 | 0 | |
102146435 | 10214643 | 28 | 20150411 | 20150415 | 0 | |
102146435 | 10214643 | 29 | 20150407 | 20150410 | 0 | |
102146435 | 10214643 | 30 | 20150410 | 20150415 | 0 | |
102146435 | 10214643 | 31 | 20150416 | 20150429 | 0 |